Director/Senior Director, Global Safety Officer

About KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc., is a global biopharmaceutical company dedicated to developing and delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. Our lead investigational product is sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE). Sebetralstat is under regulatory review by the U.S. FDA, with a PDUFA goal date of June 17, 2025. In addition, we have completed Marketing Authorization Applications for sebetralstat to the European Medicines Agency and multiple other global regulatory authorities.

About Sebetralstat

Sebetralstat is an investigational, novel oral plasma kallikrein inhibitor for the treatment of hereditary angioedema (HAE). We have filed multiple regulatory applications seeking approval of sebetralstat as the first oral, on-demand treatment for HAE in individuals aged 12 and older and are investigating its use in children aged 2 to 11. If approved, sebetralstat has the potential to become the foundational therapy for HAE management worldwide.

For more information about KalVista, please visit www.kalvista.com or follow on social media at @KalVista and LinkedIn.

About the role:

The Global Safety Officer serves as the safety expert for all clinical stage assets and marketed products at KalVista and is accountable for the safety strategy and major safety deliverables for each compound, including review and analysis of safety data from post-marketing sources and from clinical trials, the identification and investigation of safety signals, and management of benefit-risk profile for assigned compounds and products. Responsible for keeping senior management informed of safety issues and will work closely with Clinical Development and Operations as medical advisor.

Responsibilities:

• Monitor the benefit-risk profile of assigned compounds in an ongoing fashion and in accordance with Company and Pharmacovigilance (PV) processes
• Support and lead PV risk management processes including Product Safety PV Operations Review Team meetings
• Identify, prioritize and analyze safety signals and participate in discussions in relevant safety teams/committees
• Perform ongoing review of emerging safety data from various sources including published literature
• Ensure appropriate clinical safety risk communication and escalation to senior management
• Support PV vendor oversight and continuously maintain and improve effective systems to fulfil the requirements for signal detection and aggregate report compilation and reporting
• Produce high quality aggregate reports and responses to regulatory queries
• Provide strategic and proactive safety input into clinical development plans and update safety related sections of study documents including protocols, IB, and Inform Consent
• Ensure adequate labelling of safety related information
• Represent safety/PV  in cross-functional submission teams
• Ensure generation, consistency, and quality of safety sections in submission documents
• Participate in the development and review of safety agreements with third parties
• Ensure effective and timely delivery of: aggregate reports including Periodic Safety Update Reports/Periodic Benefit Risk Evaluation Reports (PSUR/PBRERs), Development Safety Update Reports (DSURs), Development Risk Management Plans (DRMPs) and Risk Managem